Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer | Zendy

Michael L. Blute | Zendy; Timothy Rushmer | Zendy; Fangfang Shi | Zendy; Benjamin Fuller | Zendy; E. Jason Abel | Zendy; David F. Jarrard | Zendy; Tracy M. Downs | Zendy

Open Access

Renin-Angiotensin Inhibitors Decrease Recurrence after Transurethral Resection of Bladder Tumor in Patients with Nonmuscle Invasive Bladder Cancer

Author(s) -

Michael L. Blute,

Timothy Rushmer,

Fangfang Shi,

Benjamin Fuller,

E. Jason Abel,

David F. Jarrard,

Tracy M. Downs

Publication year - 2015

Publication title -

the journal of urology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.402

H-Index - 256

eISSN - 1527-3792

pISSN - 0022-5347

DOI - 10.1016/j.juro.2015.05.104

Subject(s) - urology , medicine , bladder cancer , renin–angiotensin system , resection , cancer , surgery , blood pressure

Prior reports suggest that renin-angiotensin system inhibition may decrease nonmuscle invasive bladder cancer recurrence. We evaluated whether angiotensin converting enzyme inhibitor or angiotensin receptor blocker treatment at initial surgery was associated with decreased recurrence or progression in patients with nonmuscle invasive bladder cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research